DBV Technologies
Publicly owned French biopharmaceutical firm headquartered in Bagneux, France
DBV Technologies SA is a publicly owned French biopharmaceutical firm headquartered in Bagneux, France. DBV Technologies is known for developing "Viaskin" technology for administering allergens or antigens to intact skin while avoiding any transfer to the blood.
Nº Q5204430 ★★
Incomum · Organizações
DBV Technologies
Publicly owned French biopharmaceutical firm headquartered in Bagneux, France
DBV Technologies SA is a publicly owned French biopharmaceutical firm headquartered in Bagneux, France. DBV Technologies is known for developing "Viaskin" technology for administering allergens or antigens to intact skin while avoiding any transfer to the blood.
Na Wikipédia
Texto em inglês Ainda não há artigo no seu idioma: trecho em inglês.
DBV Technologies SA is a publicly owned French biopharmaceutical firm headquartered in Bagneux, France. DBV Technologies is known for developing "Viaskin" technology for administering allergens or antigens to intact skin while avoiding any transfer to the blood. Viaskin Peanut clinical development has received Fast Track designation from the US Food and Drug Administration.
Texto: Wikipédia em inglês, CC BY-SA 4.0. ·
Cartas próximas
-
Biogen
Nº Q864338 ★★
Sem ofertas
-
A
AbCellera
Company in Vancouver, Canada
Nº Q30271491 ★
Sem ofertas
-
B
Bioderma
Company in Lyon, France
Nº Q16951811 ★
Sem ofertas
-
D
Debiopharm
Biopharmaceutical group
Nº Q3020834 ★
Sem ofertas
-
Allergan
Irish tax-registered pharmaceutical company
Nº Q906187 ★
Sem ofertas
-
S
Stallergenes Greer
Biopharmaceutical company
Nº Q3496440 ★
Sem ofertas